Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic centre in France

A. Clapé, C. Muller, J. Plée, M. Viguier, C. Vanhaecke, P. Bernard

Open source

DOI
10.1111/bjd.19151
Published
2020-06-30
Container
British Journal of Dermatology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bjd.19151,
  title = {Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic centre in France},
  author = {A. Clapé and C. Muller and J. Plée and M. Viguier and C. Vanhaecke and P. Bernard},
  year = {2020},
  journal = {British Journal of Dermatology},
  doi = {10.1111/bjd.19151},
  url = {https://doi.org/10.1111/bjd.19151}
}

RIS

TY  - JOUR
TI  - Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic centre in France
AU  - A. Clapé
AU  - C. Muller
AU  - J. Plée
AU  - M. Viguier
AU  - C. Vanhaecke
AU  - P. Bernard
PY  - 2020
JO  - British Journal of Dermatology
DO  - 10.1111/bjd.19151
UR  - https://doi.org/10.1111/bjd.19151
ER  - 

APA

Clapé, A., Muller, C., Plée, J., Viguier, M., Vanhaecke, C., & Bernard, P. (2020). Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic centre in France. British Journal of Dermatology. https://doi.org/10.1111/bjd.19151

Source records